Piper Jaffray analyst Danielle Brill maintains Overweight on Global Blood Therapeutics (NASDAQ: GBT) price target of $80.00.The analyst shares a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE